Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis

Radue, Ernst-Wilhelm; O'Connor, Paul; Polman, Chris; Hohlfeld, Reinhard; Calabresi, Peter; Selmaj, Krystof; Mueller-Lenke, Nicole; Agoropoulou, Catherine; Holdbrook, Frederick; de Vera, Ana; Zhang-Auberson, Lixin; Francis, Gordon; Burtin, Pascale; Kappos, AYŞE

doi:10.1001/archneurol.2012.1051

Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis

Copy For Citation

Radue E., O'Connor P., Polman C. H., Hohlfeld R., Calabresi P., Selmaj K., ...More

ARCHIVES OF NEUROLOGY, vol.69, no.10, pp.1259-1269, 2012 (SCI-Expanded)

Publication Type: Article / Article
Volume: 69 Issue: 10
Publication Date: 2012
Doi Number: 10.1001/archneurol.2012.1051
Journal Name: ARCHIVES OF NEUROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1259-1269
Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Objective: To assess the impact of fingolimod (FTY720) therapy on magnetic resonance imaging measures of inflammatory activity and tissue damage in patients participating in a 2-year, placebo-controlled, phase 3 study.